Contact Lenses/Eye Wear News

Spectacle lenses with aspheric lenslets, also known as the Essilor Stellest lenses, were found to significantly slow myopia progression and axial elongation in children, according to results from a 2-year clinical trial presented at the virtual Association for Research in Vision and Ophthalmology meeting.

Johnson & Johnson Vision announced that the FDA approved Acuvue Abiliti Overnight orthokeratology contact lenses, designed to help manage myopia.

Chris Wroten, OD, presented an overview at this year’s SECO meeting covering a broad range of eye care technologies and treatments that became recently available or are quickly coming down the pipeline and may increase patient compliance.

ATLANTA — Alcon presented the latest innovations to the company’s products at this year’s SECO meeting, including Precision1 for Astigmatism, a new entry to the Systane eye drop line and news of an upcoming monthly reusable contact lens.

This year's SECO meeting will be a mix of virtual presentations and live sessions that will take place in Atlanta, April 28 to May 2.

Demodex folliculorum and Demodex brevis are ectoparasites of phylum Arthropoda that inhabit the skin of humans.

Johnson & Johnson introduced Acuvue Abiliti, a brand focused on creating products and services to help parents and eye care providers address the growing number of childhood myopia cases.

An investigation involving healthy adult eyes naïve to scleral contact lens wear identified a minimal effect on IOP homeostasis and optic nerve morphology after wearing lenses.

Investigators encouraged early multifocal lens intervention for patients nearing age 40 years despite finding no significant difference in comfort between multifocal and single lens wear, according to a study published in Ophthalmic and Physiological Optics.

Scleral contact lenses for the visual rehabilitation of patients with keratoconus were safe and efficacious, according to a record review published in Optometry and Vision Science.